Vathiotis IA - Search Results

1

Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis.

Vathiotis IA, Gomatou G, Stravopodis DJ, Syrigos N. Vathiotis IA, et al. Int J Mol Sci. 2021 May 20;22(10):5383. doi: 10.3390/ijms22105383. Int J Mol Sci. 2021. PMID: 34065396 Free PMC article. Review.

2

Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review.

Dimakakos E, Kotteas E, Gomatou G, Katsarou T, Vlahakos V, Vathiotis I, Talagani S, Dimitroulis I, Syrigos K. Dimakakos E, et al. Vasc Med. 2020 Jun;25(3):255-262. doi: 10.1177/1358863X19899160. Epub 2020 Mar 7. Vasc Med. 2020. PMID: 32146869 Review.

3

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review.

Vathiotis IA, Syrigos NK, Dimakakos EP. Vathiotis IA, et al. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029620979592. doi: 10.1177/1076029620979592. Clin Appl Thromb Hemost. 2021. PMID: 33464938 Free PMC article.

4

Risk Factors for Venous Thromboembolism in Patients With Small Cell Lung Cancer.

Dimakakos E, Livanios K, Vathiotis I, Gomatou G, Gkiozos I, Kotteas E, Kainis E, Syrigos K. Dimakakos E, et al. Anticancer Res. 2021 Mar;41(3):1523-1528. doi: 10.21873/anticanres.14911. Anticancer Res. 2021. PMID: 33788745

5

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer.

Moutafi MK, Tao W, Huang R, Haberberger J, Alexander B, Ramkissoon S, Ross JS, Syrigos K, Wei W, Pusztai L, Rimm DL, Vathiotis IA. Moutafi MK, et al. Among authors: vathiotis ia. J Immunother Cancer. 2021 Apr;9(4):e002230. doi: 10.1136/jitc-2020-002230. J Immunother Cancer. 2021. PMID: 33833050 Free PMC article.

6

Tumor Dormancy: Implications for Invasion and Metastasis.

Gomatou G, Syrigos N, Vathiotis IA, Kotteas EA. Gomatou G, et al. Among authors: vathiotis ia. Int J Mol Sci. 2021 May 4;22(9):4862. doi: 10.3390/ijms22094862. Int J Mol Sci. 2021. PMID: 34064392 Free PMC article. Review.

7

Association of PD-1/PD-L1 Co-location with Immunotherapy Outcomes in Non-Small Cell Lung Cancer.

Gavrielatou N, Liu Y, Vathiotis I, Zugazagoitia J, Aung TN, Shafi S, Fernandez A, Schalper K, Psyrri A, Rimm DL. Gavrielatou N, et al. Clin Cancer Res. 2022 Jan 15;28(2):360-367. doi: 10.1158/1078-0432.CCR-21-2649. Epub 2021 Oct 22. Clin Cancer Res. 2022. PMID: 34686497 Free PMC article.

8

Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer.

Trontzas IP, Vathiotis I, Economidou C, Petridou I, Gomatou G, Grammoustianou M, Tsamis I, Syrigos N, Anagnostakis M, Fyta E, Sakka V, Poulakou G, Kotteas EA, Syrigou E. Trontzas IP, et al. Vaccines (Basel). 2022 Apr 15;10(4):618. doi: 10.3390/vaccines10040618. Vaccines (Basel). 2022. PMID: 35455367 Free PMC article.

9

Development of an immunohistochemical assay for Siglec-15.

Shafi S, Aung TN, Robbins C, Zugazagoitia J, Vathiotis I, Gavrielatou N, Yaghoobi V, Fernandez A, Niu S, Liu LN, Cusumano ZT, Leelatian N, Cole K, Wang H, Homer R, Herbst RS, Langermann S, Rimm DL. Shafi S, et al. Lab Invest. 2022 Jul;102(7):771-778. doi: 10.1038/s41374-022-00785-9. Epub 2022 Apr 22. Lab Invest. 2022. PMID: 35459795 Free PMC article.

10

Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer.

Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Shafi S, et al. Among authors: vathiotis ia. Lab Invest. 2022 Oct;102(10):1143-1149. doi: 10.1038/s41374-022-00796-6. Epub 2022 May 17. Lab Invest. 2022. PMID: 35581307 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page